Erectile dysfunction in a primary care setting: results of an observational, no-control-group, prospective study with sildenafil under routine conditions of use
Author:
Publisher
Springer Science and Business Media LLC
Subject
Urology
Link
http://www.nature.com/articles/3900782.pdf
Reference42 articles.
1. NIH Consensus Development Panel of Impotence. . Impotence. JAMA 1993 270, 83–90.
2. Montague DK et al. Clinical guidelines panel of erectile dysfunction: summary report on the treatment of organic erectile dysfunction. J Urol 1996 156, 2007–2011.
3. Feldman HA et al. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol 1994 151, 54–61.
4. Martín-Morales A et al. Prevalence and independent risk factors for erectile dysfunction in Spain: results of the ‘Epidemiología de la Disfunción Eréctil Masculina’ Study. J Urol 2001 166, 569–574.
5. Foreman MM, Doherty PC. . Experimental approaches to the development of pharmacological therapies for erectile dysfunction. In: Riley AJ, Peet M, Wilson CA, eds. Sexual Pharmacology Oxford Medical Publications: Oxford 1993 87–113.
Cited by 35 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. La medicalizzazione della sessualità maschile;RIVISTA DI SESSUOLOGIA CLINICA;2018-04
2. Reasons and predictive factors for discontinuation of PDE-5 inhibitors despite successful intercourse in erectile dysfunction patients;International Journal of Impotence Research;2013-12-05
3. Enhanced understanding of the relationship between erection and satisfaction in ED treatment: application of a longitudinal mediation model;International Journal of Impotence Research;2013-06-13
4. Assessing satisfaction in men and their female partners after treatment with phosphodiesterase type 5 inhibitors for erectile dysfunction;International Journal of Impotence Research;2013-03-07
5. Correlations With Satisfaction Measures in Men Treated With Phosphodiesterase Inhibitors for Erectile Dysfunction;American Journal of Men's Health;2011-03-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3